Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)

Autor: Tatiana Kharitonova, Yury G Shvarts, Andrey F Verbovoy, Natalia S Orlova, Valentina P Puzyreva, Igor A Strokov
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: BMJ Open Diabetes Research & Care, Vol 10, Iss 3 (2022)
Druh dokumentu: article
ISSN: 2052-4897
DOI: 10.1136/bmjdrc-2022-002785
Databáze: Directory of Open Access Journals